Skip to main content
. 2020 Jun 14;22(10):1314–1324. doi: 10.1111/codi.15113

Table 5.

Survival time (in years) for all patients, from randomization.

Survival quantiles
Patient group Min.

25%

(95% CI)

50%

(95% CI)

75%

(95% CI)

Max.
Control

Group 1

(N = 47)

0.59 2.74 (1.53–3.32) 3.78 (3.10–4.64) 5.63 (4.48 to Inf) 9.05
Metastasectomy

Group 2

(N = 46)

0.17 2.90 (1.83–3.35) 3.53 (3.11–6.58) 7.46 (4.10 to Inf)

9.07

Inf, Infinity.